FTC Reconsidering Drug Chains' Divestiture Strategies - Commission's Balto
This article was originally published in The Rose Sheet
Executive Summary
The Federal Trade Commission is reconsidering its traditional strategy of requiring the divestiture of store locations before approving drug chain mergers, FTC Bureau of Competition Office of Policy and Evaluation Assistant Director David Balto told the National Association of Chain Drug Stores Aug. 31.
You may also be interested in...
FTC Public Workshop On Retail Slotting Issues Urged By Senate Committee
A Federal Trade Commission public workshop to discuss the practice of slotting in retail outlets is suggested by the Senate Committee on Small Business in an Oct. 20 letter to the commission.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program